[CRVS] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
30-Apr-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -17.09%
YoY- -11.10%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,873 -8,297 -11,580 -12,935 -11,643 -14,301 -16,036 -11.17%
Tax 923 884 -3 0 0 0 0 -
NP -8,796 -9,181 -11,580 -12,935 -11,643 -14,301 -16,036 -9.52%
Tax Rate - - - - - - - -
Total Cost 8,796 9,181 11,580 12,935 11,643 14,301 16,036 -9.52%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.19 -0.20 -0.34 -0.44 -0.40 -0.63 -0.79 -21.13%
EPS Diluted -0.19 -0.20 -0.34 -0.44 -0.40 -0.63 -0.79 -21.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.